Fighting cancer
with metabolism

We’re pioneering a powerful
new treatment paradigm

Fighting cancer
with metabolism

We’re pioneering a powerful
new treatment paradigm

Fighting cancer
with metabolism

Fighting cancer with metabolism

We’re pioneering a powerful
new treatment paradigm

Our Focus Area

Metabolic synthetic lethality: improving and expanding available drug targets

Drug targets adequately targeted without metabolic optimization
Drug targets improved by metabolic optimization
Drug targets only achievable with metabolic optimization

Metabolism independent drug targets, e.g. CDK4/6 inh.
Improving
Metabolism optimizable drug targets, e.g. PI3K inh., Chemotherapy, Radiation
Expanding
Button default text
Metabolism dependent drug targets, e.g. PHGDH inh.

UNIQUE DISCOVERY PLATFORM

Using metabolic data to discover safer, more impactful therapies

Until recently, the role of systemic and tumor metabolism in cancer care has been ignored. Faeth’s MetabOS platform provides unprecedented insights into drug-nutrient interactions across all tumor types. By incorporating metabolic optimization, Faeth is unlocking an entirely new way of treating cancer. We pair our anti-cancer drugs with metabolic optimization to achieve greater outcomes and decrease toxicity.

Input
Comprehensive
metabolic data
  • Metabolomic Network
  • Faeth Curated Single Cell RNA Sequence Database
  • FBA Model
  • Faeth Proprietary TME Database
Analysis
Metab
OS
Machine learning to repeatably & scalably investigate drug-nutrient interactions across all tumor types
Output
Interventions tailored to tumor type & genotype

Our process

The Faeth formula for achieving improved therapeutic outcomes

Therapeutics

Targeted therapies
(FTH-001, FTH-002, FTH-003)

Metabolic Optimization

Required components vary by program
Precision
nutrition
Additional
therapeutics
Faeth app

GET INVOLVED

Join a clinical trial

Faeth has multiple ongoing clinical trials. Patients on our trials have access to support from our coaches through the Faeth app, in order to make the program easier to adjust to. Our team is committed to supporting you through your journey.
View open clinical trials

our supporters

Backed by leading investors

Curious to learn more about Faeth's research?

View our Pipeline